Numerous studies suggest that SPP1 may contribute to the development and progression of cardiovascular diseases, including atherosclerosis, abdominal aortic aneurysm, dilated cardiomyopathy with heart failure, thoracic aortic dissection, and myocardial infarction, via the EMT pathway. This evidence concerns the gene SPP1 and cardiovascular disorder.